Variables and sources. Diagnoses (ICD-8 and ICD-10) and medication (ATC, Anatomical Therapeutical Chemical) codes used. (DOCX 20 kb
Supplemental material, sj-pdf-1-jso-10.1177_23971983221140538 for Worsening premature death burden g...
Table S2. SF-36 domains, SF-6D, and EQ-5D-3L scores adjusted by age and sex. (DOCX 19 kb
Previous studies of endostatin and/or vascular endothelial growth factor in SSc and MCTD. Listing of...
Overall incidence rates, mean age at diagnosis and proportion of women in 1995â2015. Description: ...
Clinical manifestation and survival rates published by different countries since 2008. (DOCX 19 kb
Figure S1. Funnel plots, forest plots, and meta-regression for the meta-analysis of SMR. Figure S2. ...
Table S1. Survival rates and survival curve for lcSSc and dcSSc. Table S2. Main characteristics of s...
Figure S1. Survival analysis based on respiratory symptoms. Figure S2. Survival analysis based on or...
Cumulative prevalence of causes of death, 2005–2011 in Denmark. †Total = 377,410. All decedents were...
Figure S2A and S2B. Death counts by cause-of-death group for Denmark (A) and Sweden (B). Colored-ver...
Contains fulltext : 48864.pdf (publisher's version ) (Closed access)PURPOSE: Studi...
OBJECTIVES: To determine the causes of death and risk factors in systemic sclerosis (SSc). METHODS: ...
Table S3. SF-36 domains, SF-6D, and EQ-5D-3L scores adjusted by age, sex, disease duration, comorbid...
Additional file 1: Supplemental Figure S1. Cumulative incidence probability of bronchiectasis (/100,...
Figure S2. The mean age-standardized musculoskeletal disorders mortality rates per million person-ye...
Supplemental material, sj-pdf-1-jso-10.1177_23971983221140538 for Worsening premature death burden g...
Table S2. SF-36 domains, SF-6D, and EQ-5D-3L scores adjusted by age and sex. (DOCX 19 kb
Previous studies of endostatin and/or vascular endothelial growth factor in SSc and MCTD. Listing of...
Overall incidence rates, mean age at diagnosis and proportion of women in 1995â2015. Description: ...
Clinical manifestation and survival rates published by different countries since 2008. (DOCX 19 kb
Figure S1. Funnel plots, forest plots, and meta-regression for the meta-analysis of SMR. Figure S2. ...
Table S1. Survival rates and survival curve for lcSSc and dcSSc. Table S2. Main characteristics of s...
Figure S1. Survival analysis based on respiratory symptoms. Figure S2. Survival analysis based on or...
Cumulative prevalence of causes of death, 2005–2011 in Denmark. †Total = 377,410. All decedents were...
Figure S2A and S2B. Death counts by cause-of-death group for Denmark (A) and Sweden (B). Colored-ver...
Contains fulltext : 48864.pdf (publisher's version ) (Closed access)PURPOSE: Studi...
OBJECTIVES: To determine the causes of death and risk factors in systemic sclerosis (SSc). METHODS: ...
Table S3. SF-36 domains, SF-6D, and EQ-5D-3L scores adjusted by age, sex, disease duration, comorbid...
Additional file 1: Supplemental Figure S1. Cumulative incidence probability of bronchiectasis (/100,...
Figure S2. The mean age-standardized musculoskeletal disorders mortality rates per million person-ye...
Supplemental material, sj-pdf-1-jso-10.1177_23971983221140538 for Worsening premature death burden g...
Table S2. SF-36 domains, SF-6D, and EQ-5D-3L scores adjusted by age and sex. (DOCX 19 kb
Previous studies of endostatin and/or vascular endothelial growth factor in SSc and MCTD. Listing of...